Shi-long Zhang
Minhang Branch
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
L-Kynurenine regulates immune response in ICIs-associated myocarditis via JAK/STAT pathway.
Journal: International immunopharmacology
Published: February 05, 2025
Cancer Cell Secreted Legumain Promotes Gastric Cancer Resistance to Anti-PD-1 Immunotherapy by Enhancing Macrophage M2 Polarization.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 27, 2024
Annonaceous acetogenins mimic AA005 targets mitochondrial trifunctional enzyme alpha subunit to treat obesity in male mice.
Journal: Nature communications
Published: September 30, 2023
Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axis.
Journal: Pharmacological research
Published: April 04, 2023
Acarbose enhances the efficacy of immunotherapy against solid tumours by modulating the gut microbiota.
Journal: Nature metabolism
Published: October 18, 2022
Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice.
Journal: Gut microbes
Published: March 08, 2022
The antitumour effects of caloric restriction are mediated by the gut microbiome.
Journal: Nature metabolism
Published: December 02, 2021
Gut and Cutaneous Microbiome Featuring Abundance of Lactobacillus reuteri Protected Against Psoriasis-Like Inflammation in Mice.
Journal: Journal of inflammation research
Published: August 31, 2021
Low EGR1 expression predicts poor prognosis in clear cell renal cell carcinoma.
Journal: Pathology, research and practice
Published: June 02, 2021
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Journal: Theranostics
Published: October 14, 2020
Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma.
Journal: Cancer medicine
Published: May 07, 2020
Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma.
Journal: Frontiers in oncology
Published: February 10, 2020
Last Updated: 09/26/2026